Alligator Bioscience AB (7AL0)
FSX
Closed
Sep 18, 2026
Day's Range
0.00010052 wk Range
0.000043Overview - 7AL0 - Alligator Bioscience AB
Key Statistics
Valuation
Enterprise Value
-18.95M
P/E (Trailing)
‪0.000020‬
PEG Ratio
‪0.00000036‬
Price / Sales (TTM)
‪0.17‬
Price / Book
‪0.01‬
EV / EBITDA
‪0.16‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-1,378.01%‬
Return on Assets
‪-89.52%‬
Return on Equity
‪-748.65%‬
Ownership
Shares Outstanding
628.10M
Float
613.86M
Held by Insiders
‪1.65%‬
Held by Institutions
‪2.88%‬
Price stats
Beta
‪1.17‬
50-Day Avg
‪0.00131‬
200-Day Avg
‪0.00494‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 7AL0 - Alligator Bioscience AB
Peers - 7AL0 - Alligator Bioscience AB
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
Profile Summary - 7AL0 - Alligator Bioscience AB
About
Alligator Bioscience AB is a clinical-stage biotechnology company focused on developing tumor-directed immuno-oncology antibody drugs, particularly those targeting the CD40 receptor pathway. Its primary purpose is to activate the patient's immune system directly within the tumor microenvironment, overcoming immune…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
